1. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind and placebo-controlled study;Camargos;American Journal of Geriatric Psychiatry
2. Trazodone and cognitive performance in Alzheimer disease;Camargos;Journal of clinical psychopharmacology,2015
3. Melatonin and bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease;Dowling;American Journal of Geriatric Psychiatry,2008
4. NCT00325728 A double-blind, randomized, placebo-controlled study of the efficacy, safety and tolerability of 8 week treatment of Rozerem 8 mg (QHS) in sleep disturbed, mild to moderately severe Alzheimer's disease subjects clinicaltrials.gov/ct2/show/NCT00325728?
5. NCT00325728 Clinical Trial Synopsis 01-05-TL-375-061, NCT#00325728: A double-blind, randomized, placebo-controlled study of the efficacy, safety and tolerability of 8 week treatment of Rozerem 8 mg (QHS) in sleep disturbed, mild to moderately severe Alzheimer’s disease subjects www.takeda.com/research/ct/pdf/report/15_Ramelteon_01-05-TL-375-061_ClinicalTrialSynopsis_NCT00325728_en.pdf